The Valley Desk

NCT03073200 · Interventional trial

Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis

Overall registry status Completed

Phase 3

Conditions Plaque Psoriasis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov